Riding the wind and breaking the waves at the right time to steadily steer forward and open up a new chapter | Shengao Pharmaceutical's 2024 Work Summary and 2025 Work Deployment Conference was successfully held

Riding the wind and breaking the waves at the right time

Steady steering ahead opens up a new chapter

Shaanxi Shengao Animal Pharmaceutical 2024 Work Summary and

 2025 Work Deployment Conference

On February 11, 2025, Shaanxi Shengao Animal Pharmaceutical Co., Ltd. held a grand conference on the 2024 Work Summary and 2025 Work Plan. The company's senior leaders, department heads, and all employees attended this grand event to review the glorious achievements of the past year, look forward to and plan the development direction for the new year.

In the past year, facing the challenges of intensified market competition and diversified demand, all employees of Shengao Pharmaceutical have united and worked hard, achieving remarkable results. Steady progress has been made in business operations, and the company has achieved results in sustained and stable development.

Sales Director ,Zhou Qi

Zhao Mengting, Vice President of Finance

Vice President of Production, Liu Kang

Zhao Kangtai, Vice President of Huan'an

The conference kicked off in a solemn atmosphere. Firstly, Sales Director Zhou Qi, Vice President of Production Liu Kang, Vice President of Finance Zhao Mengting, and Vice President of Environmental Safety Zhao Kangtai took the stage and presented in detail their respective work achievements in 2024 and work plans for 2025 in the form of PPT. The reports of the executives are detailed and accurate, fully demonstrating the steady development and significant achievements of Shengao Pharmaceutical in the past year. At the same time, the executives also elaborated on this year's work goals and plans, clarified the work direction and key tasks for the new year, and laid the foundation for Shengao Pharmaceutical to continue high-quality production.

Associate Professor of Shaanxi University of Science and Technology

Director of Shengao Pharmaceutical R&D Center
Kong Yang

Kong Yang, Associate Professor of Shaanxi University of Science and Technology and Director of the R&D Center of Shengao Pharmaceutical, has made in-depth deployments for product research and development work in 2025. She elaborated on the new projects being carried out by the R&D center in detail, and looked forward to the innovation and breakthrough directions in the field of product R&D in the future, demonstrating the vitality and forward-looking vision of the Shengao Pharmaceutical R&D center.

Associate Professor of Northwest A&F University

Director of Shengao Pharmaceutical Technology Promotion Center
Cong Rihua

Subsequently, Associate Professor Cong Rihua from Northwest A&F University and Director of Shengao Pharmaceutical Technology Promotion Center made a comprehensive plan for Shengao Business School, school enterprise cooperation, and talent cultivation in 2025. He emphasized the key role of school enterprise cooperation in promoting technological innovation, industrial upgrading, and ensuring drug feedback services, and proposed a series of specific measures to strengthen talent cultivation and deepen the integration of industry, academia, and research, aiming to promote knowledge transformation and technological upgrading through close cooperation.

General Manager Du Yufeng

At the meeting, General Manager Du Yufeng provided a comprehensive and profound summary of the work for 2024, analyzed the current situation, addressed shortcomings and deficiencies, and made detailed arrangements for the work of various departments in 2025. He stated that in 2024, the company will sail against the current and forge ahead in difficult circumstances. In the new year, we must maintain strategic determination and firm confidence in development, always putting customer needs at the center, insisting on turning inward, deepening internal changes, breaking through development difficulties, using innovation as the engine and hard work as the brush, and writing a new chapter in the development of Shengao Pharmaceutical.

Chairman Du Peng

Finally, Chairman Du Peng delivered a concluding speech. He emphasized that in the face of the current severe market environment and industry situation, all employees should face problems directly, not fear difficulties, adhere to the concept of "putting words first", take rapid action as a sharp blade, pursue the ultimate standard, always maintain an optimistic and forward attitude, embrace changes, meet challenges, and strive towards the annual goals.

Roll up your sleeves and keep going!

The time sequence changes, and those who strive for progress come first; those who move forward with dreams and courage win. Let us ignite the "fire" in our hearts and ignite the "strength" in our bodies with rock solid confidence, the determination to seize every moment, and the unyielding perseverance. Tighten the screws, tighten the mainspring, bow down to the situation, firmly implement, seize the opportunity, and move forward courageously, striving to embark on a new journey of high-quality development of the Shengao Pharmaceutical Industry.